Published in Contemp Clin Trials on October 17, 2012
Patient Activation After DXA Result Notification (PAADRN) | NCT01507662
Patient Preferences for Test Result Notification. J Gen Intern Med (2015) 1.00
Developing a bone mineral density test result letter to send to patients: a mixed-methods study. Patient Prefer Adherence (2014) 0.96
Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial. BMC Musculoskelet Disord (2016) 0.86
Improving bone mineral density reporting to patients with an illustration of personal fracture risk. BMC Med Inform Decis Mak (2014) 0.84
Understanding Preferences for Osteoporosis Information to Develop an Osteoporosis Patient Education Brochure. Perm J (2016) 0.83
Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial. J Clin Densitom (2016) 0.78
A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material. Contemp Clin Trials Commun (2016) 0.75
Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled Trial. Med Care (2017) 0.75
Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy. J Am Pharm Assoc (2003) (2017) 0.75
Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial. Perm J (2017) 0.75
The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial. Osteoporos Int (2017) 0.75
The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial. Osteoporos Int (2017) 0.75
Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale. Osteoporos Int (2017) 0.75
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform (2008) 71.12
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
EuroQol: the current state of play. Health Policy (1996) 27.78
Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care (2003) 19.69
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA (2003) 14.72
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
Development and testing of a short form of the patient activation measure. Health Serv Res (2005) 8.26
Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med (2006) 7.08
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Measuring numeracy without a math test: development of the Subjective Numeracy Scale. Med Decis Making (2007) 4.80
"I wish I had seen this test result earlier!": Dissatisfaction with test result management systems in primary care. Arch Intern Med (2004) 3.81
Timely follow-up of abnormal diagnostic imaging test results in an outpatient setting: are electronic medical records achieving their potential? Arch Intern Med (2009) 3.63
Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med (2012) 3.42
The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract (2006) 3.23
Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med (2011) 2.96
Patient notification and follow-up of abnormal test results. A physician survey. Arch Intern Med (1996) 2.42
Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33
Assessment of Preferences for self-treatment and information in health care. J Pers Soc Psychol (1980) 2.33
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol (2007) 1.80
Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study. J Clin Oncol (2010) 1.76
Failure to recognize and act on abnormal test results: the case of screening bone densitometry. Jt Comm J Qual Patient Saf (2005) 1.61
Development and evaluation of the Osteoporosis Health Belief Scale. Res Nurs Health (1991) 1.58
Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med (2007) 1.56
Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ (2008) 1.35
Initiation of osteoporosis treatment after bone mineral density testing. Osteoporos Int (2001) 1.34
Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc (2005) 1.32
Direct reporting of laboratory test results to patients by mail to enhance patient safety. J Gen Intern Med (2006) 1.25
Influence of bone densitometry results on the treatment of osteoporosis. CMAJ (2001) 1.24
Development and evaluation of the Osteoporosis Self-Efficacy Scale. Res Nurs Health (1998) 1.24
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2010) 1.19
Minimal error in self-report of having had DXA, but self-report of its results was poor. J Clin Epidemiol (2007) 1.19
Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord (2008) 1.16
Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int (2005) 1.16
Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns (2008) 1.09
A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int (2008) 1.09
Psychometric properties of the "Osteoporosis and You" questionnaire: osteoporosis knowledge deficits among older community-dwelling women. Osteoporos Int (2007) 1.05
Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res (2007) 1.03
Failure to recognize newly identified aortic dilations in a health care system with an advanced electronic medical record. Ann Intern Med (2009) 1.02
Osteoporosis knowledge, health beliefs, and DXA T-scores in men and women 50 years of age and older. Orthop Nurs (2007) 0.98
The effect on behavior and bone mineral density of individualized bone mineral density feedback and educational interventions in premenopausal women: a randomized controlled trial [NCT00273260]. BMC Public Health (2006) 0.98
Osteoporosis health belief scale: minor changes were required after telephone administration among women. J Clin Epidemiol (2004) 0.97
After the fall: women's views of fractures in relation to bone health at midlife. Women Health (2004) 0.93
Predictors of change in calcium intake in postmenopausal women after osteoporosis screening. J Nutr (2007) 0.93
"But what does it mean for me?" Primary care patients' communication preferences for test results notification. Jt Comm J Qual Patient Saf (2012) 0.93
Screening for osteoporosis: recommendation statement. Am Fam Physician (2011) 0.90
A randomized trial to assess the impact of direct reporting of DXA scan results to patients on quality of osteoporosis care. J Clin Densitom (2006) 0.87
Health Beliefs about Osteoporosis and Osteoporosis Screening in Older Women and Men. Health Educ J (2010) 0.85
Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians. Osteoporos Int (2009) 0.83
Direct disclosure of bone density results to patients: effect on knowledge of osteoporosis risk and anxiety level. Osteoporos Int (1998) 0.83
Mammography result notification letters: are they easy to read and understand? J Womens Health (Larchmt) (2011) 0.79
Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 15.06
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 12.07
X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell (2006) 7.17
Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88. Nat Biotechnol (2007) 6.21
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA (2012) 4.89
Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2004) 4.77
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) (2010) 4.65
Improved response to disasters and outbreaks by tracking population movements with mobile phone network data: a post-earthquake geospatial study in Haiti. PLoS Med (2011) 4.38
Availability of consumer prices from US hospitals for a common surgical procedure. JAMA Intern Med (2013) 4.35
Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol (2008) 3.95
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med (2011) 3.80
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) (2011) 3.66
The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab (2010) 3.61
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58
Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) (2012) 3.47
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum (2007) 3.38
Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell (2011) 3.36
Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36
A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol (2008) 3.13
Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA (2011) 3.09
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res (2007) 3.08
Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc (2006) 2.96
Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med (2003) 2.96
Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 Veterans Affairs hospitals. Ann Intern Med (2012) 2.92
The costs of critical care telemedicine programs: a systematic review and analysis. Chest (2013) 2.75
PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell (2008) 2.66
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell (2003) 2.65
Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinformatics (2006) 2.53
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res (2014) 2.52
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51
Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat (2007) 2.49
Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2002) 2.43
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet (2003) 2.41
Impact of telemedicine intensive care unit coverage on patient outcomes: a systematic review and meta-analysis. Arch Intern Med (2011) 2.41
A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res (2005) 2.35
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci (2003) 2.29
Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res (2006) 2.29
Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med (2009) 2.27
Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients. J Clin Epidemiol (2008) 2.25
Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. J Bone Miner Res (2009) 2.24
The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol (2011) 2.23
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet (2006) 2.20
The effect of adverse housing and neighborhood conditions on the development of diabetes mellitus among middle-aged African Americans. Am J Epidemiol (2007) 2.17
Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: results of a randomized controlled trial. Pharmacotherapy (2004) 2.17
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol (2012) 2.14
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol (2007) 2.13
Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry (2002) 2.13
Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat Med (2009) 2.10
Relation between hospital orthopaedic specialisation and outcomes in patients aged 65 and older: retrospective analysis of US Medicare data. BMJ (2010) 2.08
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care Res (Hoboken) (2015) 2.03
The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol (2009) 2.02
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med (2002) 2.01
Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol (2008) 2.00
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res (Hoboken) (2013) 1.92
Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response. J Clin Oncol (2012) 1.91
Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res (2005) 1.91
The association between hospital obstetrical volume and maternal postpartum complications. Am J Obstet Gynecol (2012) 1.90
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. J Clin Endocrinol Metab (2006) 1.88
ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol (2004) 1.88
Medication errors in the home: a multisite study of children with cancer. Pediatrics (2013) 1.87
Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum (2006) 1.85
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans. J Am Geriatr Soc (2004) 1.78
Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol (2008) 1.78
Quality of care indicators for gout management. Arthritis Rheum (2004) 1.77
Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum (2004) 1.76
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell (2012) 1.75
Randomized trial to improve fracture prevention in nursing home residents. Am J Med (2007) 1.75
Financial payments by orthopedic device makers to orthopedic surgeons. Arch Intern Med (2011) 1.74
Inner city, middle-aged African Americans have excess frank and subclinical disability. J Gerontol A Biol Sci Med Sci (2005) 1.74
Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report. J Gen Intern Med (2003) 1.70
Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report. Ann Allergy Asthma Immunol (2003) 1.70
ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development. Dev Cell (2010) 1.68
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut (2010) 1.67
Neighborhood conditions and risk of incident lower-body functional limitations among middle-aged African Americans. Am J Epidemiol (2006) 1.66
Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf (2006) 1.65
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene (2004) 1.64
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc (2010) 1.62
Validity of gout diagnoses in administrative data. Arthritis Rheum (2007) 1.62
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res (2014) 1.62
Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation (2007) 1.61
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum (2005) 1.58
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res (2013) 1.58
The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol (2008) 1.58
Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. J Biol Chem (2012) 1.58
Forceps delivery volumes in teaching and nonteaching hospitals: are volumes sufficient for physicians to acquire and maintain competence? Acad Med (2014) 1.55
Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. J Bone Miner Res (2008) 1.55
Female ground tits prefer relatives as extra-pair partners: driven by kin-selection? Mol Ecol (2011) 1.54
A boosting approach for motif modeling using ChIP-chip data. Bioinformatics (2005) 1.53